Using secukinumab in a patient with endplate inflammation complicated by hepatitis B virus infection.
10.1097/CM9.0000000000001801
- Author:
Rui-Hong HOU
1
;
Xiao-Ting WEN
2
;
Qian WANG
1
;
Li WANG
1
Author Information
1. Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China.
2. Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi 030053, China.
- Publication Type:Letter
- MeSH:
Antibodies, Monoclonal, Humanized/therapeutic use*;
Hepatitis B/drug therapy*;
Hepatitis B virus;
Humans;
Inflammation
- From:
Chinese Medical Journal
2021;134(21):2644-2646
- CountryChina
- Language:English
